mktcap_usd=475402
ConsensRecom=2.45
earning_yield=3.96%
growth=4.65%
dilution=-0.77%
div_ratio=48.26%
sh_payout_ratio=67.21%
margin=17.27%
cfmargin=14.04%
ratiopaid=56.78%
sratiopaid=25.77%
ratioConsens=1.19
Description
Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer Health, Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, womens health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The MedTech segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.
Income and Cashflow Statements USD
| EndDate | 2017-01-01 | 2017-12-31 | 2018-12-30 | 2019-12-29 | 2021-01-03 | 2022-01-02 | 2023-01-01 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-02-27 | 2019-02-20 | 2019-02-20 | 2020-02-18 | 2021-02-22 | 2022-02-17 | 2023-02-16 | NaN | NaN |
| period | 12M | 12M | 12M | 12M | 12M | 12M | 12M | NaN | NaN |
| rev | 71890 | 76450 | 81581 | 82059 | 82584 | 93775 | 94943 | 83326 | 8440 |
| revgrowth | NaN | 6.15% | 6.50% | 0.58% | 0.64% | 12.71% | 1.24% | 4.64% | 4.79% |
| earn | 16540 | 1300 | 15297 | 15119 | 14714 | 20878 | 17941 | 14541 | 6218 |
| earnx | 16540 | 14300 | 15297 | 15119 | 14414 | 20878 | 17941 | 16356 | 2368 |
| margin | 23.01% | 1.70% | 18.75% | 18.42% | 17.82% | 22.26% | 18.90% | 17.27% | 7.15% |
| xmargin | 23.01% | 18.71% | 18.75% | 18.42% | 17.45% | 22.26% | 18.90% | 19.64% | 2.11% |
| earningyld | 4.43% | 0.29% | 3.47% | 3.39% | 2.94% | 3.88% | 3.38% | 3.11% | 1.33% |
| cfop | 18767 | 21056 | 22201 | 23416 | 23536 | 23410 | 21194 | 21940 | 1749 |
| cfinv | -4761 | -14868 | -3167 | -6194 | -20825 | -8683 | -12371 | -10124 | 6282 |
| cffin | -8551 | -7673 | -18510 | -18015 | -6120 | -14047 | -8871 | -11684 | 5116 |
| cfopmargin | 26.11% | 27.54% | 27.21% | 28.54% | 28.50% | 24.96% | 22.32% | 26.45% | 2.22% |
| cfinvmargin | -6.62% | -19.45% | -3.88% | -7.55% | -25.22% | -9.26% | -13.03% | -12.14% | 7.67% |
| cffinmargin | -11.89% | -10.04% | -22.69% | -21.95% | -7.41% | -14.98% | -9.34% | -14.04% | 6.12% |
| shares | 3266 | 3215 | 3196 | 3144 | 3128 | 3132 | 3120 | 3171 | 55.4 |
| fx | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0 |
| price | 114 | 139 | 138 | 142 | 160 | 172 | 170 | 148 | 20.7 |
| dilution | NaN | -1.58% | -0.61% | -1.64% | -0.51% | 0.12% | -0.38% | -0.76% | 0.70% |
| dividend | 8621 | 8943 | 9494 | 9917 | 10481 | 11032 | 11682 | 10024 | 1111 |
| sharebb | NaN | 6464 | 2692 | 7271 | 2405 | -641 | 2021 | 3369 | 2970 |
| ltdebtbb | NaN | -8233 | 2991 | 1190 | -6141 | 2650 | 3097 | -741 | 5083 |
| mgtbb | NaN | -499 | -3333 | 363 | 625 | -1006 | 7929 | 680 | 3821 |
| divyld | 2.31% | 2.00% | 2.15% | 2.23% | 2.09% | 2.05% | 2.20% | 2.15% | 0.11% |
| sharebbyld | NaN | 1.58% | 0.61% | 1.64% | 0.51% | -0.12% | 0.38% | 0.76% | 0.70% |
| mgtyld | NaN | -0.11% | -0.76% | 0.08% | 0.12% | -0.19% | 1.49% | 0.11% | 0.75% |
Balance Sheet
| EndDate | 2017-01-01 | 2017-12-31 | 2018-12-30 | 2019-12-29 | 2021-01-03 | 2022-01-02 | 2023-01-01 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-02-27 | 2019-02-20 | 2019-02-20 | 2020-02-18 | 2021-02-22 | 2022-02-17 | 2023-02-16 | NaN | NaN |
| mktcap | 373094 | 446765 | 440931 | 445404 | 501247 | 537645 | 530482 | 467938 | 58539 |
| mktcapgrowth | NaN | 18.02% | -1.31% | 1.01% | 11.81% | 7.01% | -1.34% | 5.87% | 7.89% |
| totAsset | 141208 | 157303 | 152954 | 157728 | 174894 | 182018 | 187378 | 164783 | 16888 |
| assetgrowth | NaN | 10.79% | -2.80% | 3.07% | 10.33% | 3.99% | 2.90% | 4.71% | 5.13% |
| curAsset | 65032 | 43088 | 46033 | 45274 | 51237 | 60979 | 55294 | 52420 | 8376 |
| curAssetPct | 46.05% | 27.39% | 30.10% | 28.70% | 29.30% | 33.50% | 29.51% | 32.08% | 6.44% |
| totLiab | 70790 | 97143 | 93202 | 98257 | 111616 | 107995 | 110574 | 98511 | 14176 |
| totLiabPct | 50.13% | 61.76% | 60.93% | 62.30% | 63.82% | 59.33% | 59.01% | 59.61% | 4.50% |
| curLiab | 26287 | 30537 | 31230 | 35964 | 42493 | 45226 | 55802 | 38220 | 10262 |
| curLiabPct | 18.62% | 19.41% | 20.42% | 22.80% | 24.30% | 24.85% | 29.78% | 22.88% | 3.87% |
| ltDebt | 22442 | 30675 | 27684 | 26494 | 32635 | 29985 | 26888 | 28115 | 3341 |
| ltDebtPct | 15.89% | 19.50% | 18.10% | 16.80% | 18.66% | 16.47% | 14.35% | 17.11% | 1.77% |
| Equity | 70418 | 60160 | 59752 | 59471 | 63278 | 74023 | 76804 | 66272 | 7340 |
| EquityPct | 49.87% | 38.24% | 39.07% | 37.70% | 36.18% | 40.67% | 40.99% | 40.39% | 4.50% |
| PB | 5.30 | 7.43 | 7.38 | 7.49 | 7.92 | 7.26 | 6.91 | 7.10 | 84.86% |
Beta
len=92.0
mean=3.98%
sd=15.66%
alpha=0.03%
beta=53.86%
r_sq=32.62%
lastdate=2023-03-17
firstdate=2016-05-31
logret1y=-15.11%
Financial Snapshot
CompanyName=Johnson & Johnson
ID=1
Name=Ordinary Shares
Ticker=JNJ
ISIN=None
RIC=JNJ
DisplayRIC=JNJ.N
InstrumentPI=323091
QuotePI=1090456
InstrumentPermID=8590923462
QuotePermID=55838323464
Exchange=New York Stock Exchange
ExchangeCode=NYSE
ExchangeCountry=USA
CoStatus=Active
CoType=Equity Issue
LastModified=2023-02-21
LatestAvailableAnnual=2023-01-01
LatestAvailableInterim=2023-01-01
Employees=152700
SharesOut=3.120e+09
TotalFloat=2.601e+09
ReportingCurrency=USD
MostRecentExchange=1.0
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
NPRICE=152
NHIG=187
NLOW=151
PDATE=2023-03-17
VOL10DAVG=9.29
EV=491542
MKTCAP=475402
AREV=94943
AEBITD=34685
ANIAC=17941
AEPSXCLXOR=6.74
AREVPS=35.7
ABVPS=29.4
ACSHPS=9.00
ACFSHR=9.36
ADIVSHR=4.45
AGROSMGN=67.4
AROEPCT=23.8
APR2REV=5.01
APEEXCLXOR=22.6
APRICE2BK=5.19
ConsRecom=2.45
TargetPrice=182
ProjLTGrowthRate=3.94
ProjPE=14.5
ProjSales=97834
ProjSalesQ=23659
ProjEPS=10.5
ProjEPSQ=2.52
ProjProfit=27774
ProjDPS=4.66
quoteccy=USD
quotefx=100.00%
exchgccy=USD
exchgfx=100.00%
tick=None
exchg=None
Valuation
ticker=JNJ
exchg=AMEX
RIC=JNJ
CompanyName=Johnson & Johnson
ExchangeCode=NYSE
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
sector=56 Healthcare
region=us
ccy=USD
fx=100.00%
mktcap_usd=475402
float_usd=396325
ConsensRecom=2.45
earning_yield=3.96%
growth=4.65%
dilution=-0.77%
margin=17.27%
searning_yield=2.44%
sgrowth=0.26%
smargin=10.65%
sdilution=-0.12%
projearning_yield=6.67%
earning_excl_yield=4.33%
div_ratio=48.26%
bb_ratio=18.95%
sh_payout_ratio=67.21%
PS=4.28
price=152
ratio=56.78%
sratio=25.77%
sratiopaid=25.77%
ratioConsens=1.19
turnover=50.61%
cfmargin=14.04%
rdmargin=14.19%
scfmargin=8.38%
quoteccy=USD
quotefx=100.00%
ratiopaid=56.78%
dt=2023-03-17
assetgrowth=4.70%
dlnfx=0